In this episode, we are exploring The Future of Voice Biomarkers (and maybe coining the term “voice-omics”!) and the potential to diagnose medical conditions based on voice. We are speaking to
Ed Kliphuis, Investment Director at
M Ventures, the corporate venture capital arm of Merck KGaA. Ed spoke with us about their recent investment into
Sonde Health, a digital medicine company developing diagnostic tools based on voice biomarkers.